Center Laboratories, Inc. (4123)
TWSE
Closed
Aug 25, 2026
Day's Range
32.0052 wk Range
31.53Overview - 4123 - Center Laboratories, Inc.
Key Statistics
Valuation
Enterprise Value
26.26B
P/E (Trailing)
‪81.12‬
PEG Ratio
‪0.30‬
Price / Sales (TTM)
‪15.49‬
Price / Book
‪1.50‬
EV / EBITDA
‪117.89‬
Profitability
Gross Margin
‪46.58%‬
Profit Margin
‪61.50%‬
Operating Margin
‪112.45%‬
Return on Assets
‪0.14%‬
Return on Equity
‪6.00%‬
Ownership
Shares Outstanding
746.53M
Float
592.89M
Held by Insiders
‪25.46%‬
Held by Institutions
‪7.43%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪35.70‬
200-Day Avg
‪37.47‬
Dividends
Payout Ratio
‪179.58%‬
Frequency
Annual
Market Cap - 4123 - Center Laboratories, Inc.
Peers - 4123 - Center Laboratories, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.
Profile Summary - 4123 - Center Laboratories, Inc.
About
Center Laboratories, Inc. is a pharmaceutical company specializing in the development, manufacturing, and distribution of medications primarily within Taiwan and expanding internationally. The firm is recognized for a broad product portfolio that includes general pharmaceuticals such as antipyretics, analgesics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
